Department of Urology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.
Department of Laboratory Medicine and Pathology, Faculty of Medicine and Dentistry, The University of Alberta, Edmonton, Alberta T6G 2R3, Canada.
Nat Rev Urol. 2016 Mar;13(3):168-77. doi: 10.1038/nrurol.2015.315. Epub 2016 Feb 2.
Erectile dysfunction (ED) has detrimental social and psychological effects on the quality of life of affected individuals and their sexual partners. When medical intervention is introduced to treat ED, physicians, nurses, and clinical educators should consider this disorder as a shared health problem for the men with ED and their sexual partners. New therapeutics such as phosphodiesterase-5 inhibitors improve erectile function in affected men, and the ultimate goal of medical intervention for ED should be achievement of a satisfactory sex life for couples engaged sexual relationships. Sexual partners of men with ED have an important role in its management and improvement in quality of sex life; therefore, they should be involved in assessment of, diagnosis, education, counselling, and choice of therapy. This sexual- partner-engaged approach might assist treatment and rehabilitation, helping the couples affected by ED to achieve a high-quality sex life.
勃起功能障碍（ED）对患者及其性伴侣的生活质量具有有害的社会和心理影响。当引入医学干预来治疗 ED 时，医生、护士和临床教育者应将这种疾病视为 ED 患者及其性伴侣共同的健康问题。新型治疗药物如磷酸二酯酶-5 抑制剂可改善受影响男性的勃起功能，ED 医学干预的最终目标应为使进行性生活的伴侣获得满意的性生活。ED 男性的性伴侣在其管理和改善性生活质量方面发挥着重要作用；因此，他们应该参与评估、诊断、教育、咨询和治疗选择。这种伴侣参与的方法可能有助于治疗和康复，帮助受 ED 影响的夫妇获得高质量的性生活。
